Page last updated: 2024-09-03

taraxasterol and cyclin d1

taraxasterol has been researched along with cyclin d1 in 2 studies

Compound Research Comparison

Studies
(taraxasterol)
Trials
(taraxasterol)
Recent Studies (post-2010)
(taraxasterol)
Studies
(cyclin d1)
Trials
(cyclin d1)
Recent Studies (post-2010) (cyclin d1)
5604410,885705,157

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bao, T; Ke, Y; Kui, X; Li, Y; Wang, L; Wang, W; Wang, Y; Xiao, C; Zhang, C; Zhou, D; Zhou, H; Zhou, Q1
Li, J; Xin, C; Yang, J; Yin, G1

Other Studies

2 other study(ies) available for taraxasterol and cyclin d1

ArticleYear
Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression.
    Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Nerve Tissue Proteins; Proto-Oncogene Proteins c-bcl-2; Sterols; Triterpenes; Xenograft Model Antitumor Assays

2018
Taraxasterol suppresses the proliferation and tumor growth of androgen-independent prostate cancer cells through the FGFR2-PI3K/AKT signaling pathway.
    Scientific reports, 2023, 08-11, Volume: 13, Issue:1

    Topics: Androgens; Animals; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Male; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction

2023